{
  "nodes": [
    {
      "id": "node_001",
      "content": "Stage IIIB (T4, N2) \nStage IIIC (T4, N3)",
      "parent_ids": [],
      "children_ids": [
        "node_002"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_002",
      "content": "• Molecular testing for EGFR\n• FDG-PET/CT scan^k (if not previously done)\n• Brain MRI with contrast^r\n• Pathologic confirmation of N2–3 disease by either:\n‣ Mediastinoscopy\n‣ Supraclavicular lymph node biopsy\n‣ Thoracoscopy\n‣ Needle biopsy\n‣ Mediastinotomy\n‣ EUS biopsy\n‣ EBUS biopsy",
      "parent_ids": [
        "node_001"
      ],
      "children_ids": [
        "node_003",
        "node_004",
        "node_005"
      ],
      "tree_ids": [],
      "footnote_labels": [
        "k",
        "r"
      ]
    },
    {
      "id": "node_003",
      "content": "Contralateral mediastinal node negative",
      "parent_ids": [
        "node_002"
      ],
      "children_ids": [
        "node_006",
        "node_007"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_004",
      "content": "Contralateral mediastinal node positive (T4, N3)",
      "parent_ids": [
        "node_002"
      ],
      "children_ids": [
        "node_009"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_005",
      "content": "Metastatic disease",
      "parent_ids": [
        "node_002"
      ],
      "children_ids": [
        "node_012"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_006",
      "content": "Ipsilateral mediastinal node negative (T4, N0–1)",
      "parent_ids": [
        "node_003"
      ],
      "children_ids": [
        "node_008"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_007",
      "content": "Ipsilateral mediastinal node positive (T4, N2)",
      "parent_ids": [
        "node_003"
      ],
      "children_ids": [
        "node_009"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_008",
      "content": "Treatment for Stage IIIA (NSCL-7)",
      "parent_ids": [
        "node_006"
      ],
      "children_ids": [],
      "tree_ids": [
        "NSCL-7"
      ],
      "footnote_labels": []
    },
    {
      "id": "node_009",
      "content": "Definitive concurrent chemoradiation^n,t (category 1)",
      "parent_ids": [
        "node_004",
        "node_007"
      ],
      "children_ids": [
        "node_010"
      ],
      "tree_ids": [],
      "footnote_labels": [
        "n",
        "t"
      ]
    },
    {
      "id": "node_010",
      "content": "Durvalumab^t,v (if no EGFR exon 19 deletion or L858R) (category 1)\nor\nOsimertinib^t,v (if EGFR exon 19 deletion or L858R) (category 1)",
      "parent_ids": [
        "node_009"
      ],
      "children_ids": [
        "node_011"
      ],
      "tree_ids": [],
      "footnote_labels": [
        "t",
        "v"
      ]
    },
    {
      "id": "node_011",
      "content": "Surveillance (NSCL-17)",
      "parent_ids": [
        "node_010"
      ],
      "children_ids": [],
      "tree_ids": [
        "NSCL-17"
      ],
      "footnote_labels": []
    },
    {
      "id": "node_012",
      "content": "See Treatment for Metastasis limited sites (NSCL-15) or distant disease (NSCL-18)",
      "parent_ids": [
        "node_005"
      ],
      "children_ids": [],
      "tree_ids": [
        "NSCL-15",
        "NSCL-18"
      ],
      "footnote_labels": []
    },
    {
      "id": "node_013",
      "content": "Stage IVA, M1a: pleural or pericardial effusion",
      "parent_ids": [],
      "children_ids": [
        "node_014"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_014",
      "content": "• FDG-PET/CT scan^k (if not previously done)\n• Brain MRI with contrast^r\n• Biomarker testing (NSCL-19)\n• Thoracentesis or pericardiocentesis ± thoracoscopy if thoracentesis indeterminate",
      "parent_ids": [
        "node_013"
      ],
      "children_ids": [
        "node_015",
        "node_016"
      ],
      "tree_ids": [
        "NSCL-19"
      ],
      "footnote_labels": [
        "k",
        "r"
      ]
    },
    {
      "id": "node_015",
      "content": "Negative^ff",
      "parent_ids": [
        "node_014"
      ],
      "children_ids": [
        "node_017"
      ],
      "tree_ids": [],
      "footnote_labels": [
        "ff"
      ]
    },
    {
      "id": "node_016",
      "content": "Positive^ff",
      "parent_ids": [
        "node_014"
      ],
      "children_ids": [
        "node_018"
      ],
      "tree_ids": [],
      "footnote_labels": [
        "ff"
      ]
    },
    {
      "id": "node_017",
      "content": "Treatment according to TNM stage",
      "parent_ids": [
        "node_015"
      ],
      "children_ids": [],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_018",
      "content": "Local therapy if necessary (eg, pleurodesis, ambulatory small catheter drainage, pericardial window) + treatment for stage IV disease solitary site or distant disease (NSCL-19)",
      "parent_ids": [
        "node_016"
      ],
      "children_ids": [],
      "tree_ids": [
        "NSCL-19"
      ],
      "footnote_labels": []
    }
  ],
  "tree_references": [
    {
      "from_tree": "NSCL-14",
      "to_tree": "NSCL-7",
      "description": "Treatment for Stage IIIA"
    },
    {
      "from_tree": "NSCL-14",
      "to_tree": "NSCL-17",
      "description": "Surveillance"
    },
    {
      "from_tree": "NSCL-14",
      "to_tree": "NSCL-15",
      "description": "Treatment for Metastasis limited sites"
    },
    {
      "from_tree": "NSCL-14",
      "to_tree": "NSCL-18",
      "description": "Treatment for Metastasis distant disease"
    },
    {
      "from_tree": "NSCL-14",
      "to_tree": "NSCL-19",
      "description": "Biomarker testing or treatment for stage IV disease"
    }
  ],
  "footnotes": [
    {
      "label": "k",
      "content": "FDG-PET/CT performed skull base to mid-thigh. Positive FDG-PET/CT scan findings for distant disease need pathologic or other radiologic confirmation. If FDG-PET/CT scan is positive in the mediastinum, lymph node status needs pathologic confirmation."
    },
    {
      "label": "n",
      "content": "Principles of Radiation Therapy (NSCL-C)."
    },
    {
      "label": "r",
      "content": "If MRI is not possible, CT of head with contrast."
    },
    {
      "label": "t",
      "content": "Concurrent Chemoradiation Regimens (NSCL-F)."
    },
    {
      "label": "v",
      "content": "For patients who have received sequential chemoradiation, durvalumab can be considered as consolidation immunotherapy or, if EGFR exon 19 deletion or L858R, osimertinib is recommended."
    },
    {
      "label": "ff",
      "content": "Most pleural (pericardial) effusions with lung cancer are a result of the tumor. In a few patients, however, multiple microscopic examinations of pleural (pericardial) fluid are negative for tumor, and fluid is non-bloody and not an exudate. If these elements and clinical judgment dictate that the effusion is not related to the tumor, the effusion should be excluded as a staging descriptor."
    }
  ],
  "extraction_confidence": 0.98,
  "image_title": "NCCN Guidelines Version 3.2025 Non-Small Cell Lung Cancer",
  "tree_id": "NSCL-14",
  "keywords": [
    "EGFR",
    "osimertinib",
    "durvalumab"
  ]
}
